Conroy Kevin T — SEC insider filings
SEC reporting owner CIK 1306119. 72 insider filings on record with FilingPulse; latest filed 2026-10-02.
Transaction summary — filings shown
Covers the 50 most recent of 72 filings on record, filed 2021-08-04 to 2026-10-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 19,500 shares, $1,001,325 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 19 legs across 19 filings — 215,321 shares, $16,827,866 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 129.
- Largest priced transaction: sale of 19,970 shares @ $107.50 ($2,146,775) in EXACT SCIENCES CORP, filed 2021-08-04.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| EXACT SCIENCES CORP (EXAS) | President and CEO, Director | 33 | 1 leg · 19,500 sh · $1,001,325 | 19 legs · 215,321 sh · $16,827,866 | 100 |
| ALIGN TECHNOLOGY INC (ALGN) | Director | 4 | — | — | 10 |
| Epizyme, Inc. (EPZM) | Director | 6 | — | — | 8 |
| ABBOTT LABORATORIES (ABT) | Director | 4 | — | — | 4 |
| Adaptive Biotechnologies Corp (ADPT) | Director | 2 | — | — | 4 |
| SomaLogic, Inc. (SLGCW) | Director | 1 | — | — | 3 |
Insider filings — Conroy Kevin T
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-02 | 4 | ABBOTT LABORATORIES (ABT) | Grant/award (A): 318 (derivative) @ $98.83 | EDGAR |
| 2026-09-25 | 4 | ABBOTT LABORATORIES (ABT) | Tax withholding (F): 52,507 @ $103.99 | EDGAR |
| 2026-07-01 | 4 | ABBOTT LABORATORIES (ABT) | Grant/award (A): 231 (derivative) @ $90.74 | EDGAR |
| 2026-05-22 | 4 | ALIGN TECHNOLOGY INC (ALGN) | Option exercise (M): 1,745 @ $0 · Option exercise (M): 1,745 (derivative) @ $0 · Grant/award (A): 1,836 (derivative) @ $0 | EDGAR |
| 2026-04-28 | 4 | ABBOTT LABORATORIES (ABT) | Grant/award (A): 2,286 @ $0 | EDGAR |
| 2026-03-23 | 4 | EXACT SCIENCES CORP (EXAS) | Grant/award (A): 119,312 @ $0 · Disposition to issuer (D): 1,397,738 · Disposition to issuer (D): 29,061 · Disposition to issuer (D): 46,538 · Disposition to issuer (D): 86,750 · Disposition to issuer (D): 117,427 · +8 more | EDGAR |
| 2026-03-03 | 4 | EXACT SCIENCES CORP (EXAS) | Option exercise (M): 18,143 @ $0 · Tax withholding (F): 8,528 @ $103.25 · Option exercise (M): 22,168 @ $0 · Tax withholding (F): 10,419 @ $103.25 · Option exercise (M): 27,786 @ $0 · Tax withholding (F): 13,060 @ $103.25 · +3 more | EDGAR |
| 2026-02-27 | 4 | EXACT SCIENCES CORP (EXAS) | Grant/award (A): 13,181 @ $0 · Tax withholding (F): 6,196 @ $103.45 · Grant/award (A): 154,829 (derivative) @ $0 | EDGAR |
| 2025-12-30 | 4 | EXACT SCIENCES CORP (EXAS) | Grant/award (A): 244,931 @ $0 · Tax withholding (F): 115,118 @ $101.82 · Grant/award (A): 138,326 @ $0 · Tax withholding (F): 65,014 @ $101.82 · Grant/award (A): 330,674 @ $0 · Tax withholding (F): 155,417 @ $101.82 | EDGAR |
| 2025-05-22 | 4 | ALIGN TECHNOLOGY INC (ALGN) | Option exercise (M): 1,148 @ $0 · Option exercise (M): 1,148 (derivative) @ $0 · Grant/award (A): 1,745 (derivative) @ $0 | EDGAR |
| 2025-03-10 | 4 | EXACT SCIENCES CORP (EXAS) | Option exercise (M): 66,723 @ $22.38 · Tax withholding (F): 48,929 @ $47.06 · Option exercise (M): 66,723 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | EXACT SCIENCES CORP (EXAS) | Option exercise (M): 18,143 @ $0 · Tax withholding (F): 8,528 @ $47.82 · Option exercise (M): 22,167 @ $0 · Tax withholding (F): 10,419 @ $47.82 · Option exercise (M): 18,143 (derivative) @ $0 · Option exercise (M): 22,167 (derivative) @ $0 | EDGAR |
| 2025-02-26 | 4 | EXACT SCIENCES CORP (EXAS) | Option exercise (M): 13,180 @ $0 · Tax withholding (F): 6,195 @ $51.28 · Grant/award (A): 111,146 (derivative) @ $0 · Option exercise (M): 13,180 (derivative) @ $0 | EDGAR |
| 2025-02-21 | 4 | EXACT SCIENCES CORP (EXAS) | Option exercise (M): 10,374 @ $0 · Tax withholding (F): 3,271 @ $49.63 · Grant/award (A): 48,044 @ $0 · Tax withholding (F): 21,140 @ $50.48 · Option exercise (M): 10,374 (derivative) @ $0 | EDGAR |
| 2024-11-13 | 4 | EXACT SCIENCES CORP (EXAS) | Purchase (P): 19,500 @ $51.35 | EDGAR |
| 2024-05-24 | 4 | ALIGN TECHNOLOGY INC (ALGN) | Option exercise (M): 660 @ $0 · Option exercise (M): 660 (derivative) @ $0 · Grant/award (A): 1,148 (derivative) @ $0 | EDGAR |
| 2024-05-02 | 4 | EXACT SCIENCES CORP (EXAS) | Grant/award (A): 2,489 @ $0 · Grant/award (A): 708 @ $30.02 · Sale (S): 1,155 @ $60.15 | EDGAR |
| 2024-03-04 | 4 | EXACT SCIENCES CORP (EXAS) | Option exercise (M): 18,143 @ $0 · Sale (S): 8,271 @ $59.32 · Option exercise (M): 18,143 (derivative) @ $0 | EDGAR |
| 2024-02-28 | 4 | EXACT SCIENCES CORP (EXAS) | Option exercise (M): 13,181 @ $0 · Sale (S): 6,263 @ $56.89 · Option exercise (M): 13,181 (derivative) @ $0 · Grant/award (A): 88,671 (derivative) @ $0 | EDGAR |
| 2024-02-26 | 4 | EXACT SCIENCES CORP (EXAS) | Option exercise (M): 102,837 @ $13.96 · Tax withholding (F): 61,560 @ $57.53 · Option exercise (M): 102,837 (derivative) @ $0 | EDGAR |
| 2024-02-23 | 4 | EXACT SCIENCES CORP (EXAS) | Grant/award (A): 23,238 @ $0 · Sale (S): 11,565 @ $59.78 | EDGAR |
| 2024-02-22 | 4 | EXACT SCIENCES CORP (EXAS) | Option exercise (M): 10,374 @ $0 · Sale (S): 4,975 @ $61.50 · Option exercise (M): 10,374 (derivative) @ $0 | EDGAR |
| 2024-02-16 | 4 | EXACT SCIENCES CORP (EXAS) | Grant/award (A): 709 @ $30.02 · Option exercise (M): 31,133 @ $0 · Sale (S): 14,791 @ $61.43 · Option exercise (M): 31,133 (derivative) @ $0 | EDGAR |
| 2023-12-07 | 4 | ALIGN TECHNOLOGY INC (ALGN) | Grant/award (A): 660 (derivative) @ $0 | EDGAR |
| 2023-03-08 | 4 | Adaptive Biotechnologies Corp (ADPT) | Grant/award (A): 14,775 @ $0 · Grant/award (A): 23,329 (derivative) @ $0 | EDGAR |
| 2023-03-01 | 4 | EXACT SCIENCES CORP (EXAS) | Option exercise (M): 13,180 @ $0 · Option exercise (M): 9,312 @ $0 · Sale (S): 10,416 @ $61.12 · Option exercise (M): 13,180 (derivative) @ $0 · Option exercise (M): 9,312 (derivative) @ $0 | EDGAR |
| 2023-02-28 | 4 | EXACT SCIENCES CORP (EXAS) | Grant/award (A): 72,572 (derivative) @ $0 | EDGAR |
| 2023-02-23 | 4 | EXACT SCIENCES CORP (EXAS) | Option exercise (M): 10,374 @ $0 · Sale (S): 4,764 @ $62.72 · Option exercise (M): 10,374 (derivative) @ $0 | EDGAR |
| 2023-02-16 | 4 | EXACT SCIENCES CORP (EXAS) | Option exercise (M): 31,132 @ $0 · Sale (S): 14,617 @ $65.59 · Option exercise (M): 31,132 (derivative) @ $0 | EDGAR |
| 2023-02-14 | 4 | EXACT SCIENCES CORP (EXAS) | Option exercise (M): 9,705 @ $0 · Sale (S): 4,527 @ $64.55 · Option exercise (M): 9,705 (derivative) @ $0 | EDGAR |
| 2022-08-16 | 4 | Epizyme, Inc. (EPZM) | Disposition to issuer (D): 53,324 · Disposition to issuer (D): 8,994 | EDGAR |
| 2022-07-06 | 4 | EXACT SCIENCES CORP (EXAS) | Grant/award (A): 328 @ $47.41 · Sale (S): 7 @ $40.75 | EDGAR |
| 2022-07-05 | 4 | Epizyme, Inc. (EPZM) | Grant/award (A): 10,204 @ $1.47 | EDGAR |
| 2022-05-19 | 4 | Epizyme, Inc. (EPZM) | Grant/award (A): 8,994 @ $0 · Grant/award (A): 41,006 (derivative) @ $0 | EDGAR |
| 2022-04-01 | 4 | Epizyme, Inc. (EPZM) | Grant/award (A): 13,043 @ $1.15 | EDGAR |
| 2022-03-18 | 4 | EXACT SCIENCES CORP (EXAS) | Option exercise (M): 229,757 @ $5.70 · Option exercise (M): 4,612 @ $21.68 · Option exercise (M): 2,253 @ $44.37 · Option exercise (M): 229,757 (derivative) @ $0 · Option exercise (M): 4,612 (derivative) @ $0 · Option exercise (M): 2,253 (derivative) @ $0 | EDGAR |
| 2022-03-02 | 4 | EXACT SCIENCES CORP (EXAS) | Option exercise (M): 20,575 @ $0 · Option exercise (M): 9,312 @ $0 · Sale (S): 14,299 @ $76.69 · Option exercise (M): 20,575 (derivative) @ $0 · Option exercise (M): 9,312 (derivative) @ $0 | EDGAR |
| 2022-03-01 | 4 | EXACT SCIENCES CORP (EXAS) | Grant/award (A): 52,722 (derivative) @ $0 | EDGAR |
| 2022-02-25 | 4 | EXACT SCIENCES CORP (EXAS) | Option exercise (M): 58,643 @ $0 · Sale (S): 27,126 @ $70.10 · Option exercise (M): 58,643 (derivative) @ $0 | EDGAR |
| 2022-02-24 | 4 | EXACT SCIENCES CORP (EXAS) | Option exercise (M): 10,373 @ $0 · Sale (S): 5,188 @ $69.05 · Option exercise (M): 10,373 (derivative) @ $0 | EDGAR |
| 2022-02-16 | 4 | EXACT SCIENCES CORP (EXAS) | Option exercise (M): 94,425 @ $9.07 · Option exercise (M): 96,758 @ $10.82 · Option exercise (M): 31,133 @ $78.33 · Sale (S): 14,409 @ $79.55 · Option exercise (M): 94,425 (derivative) @ $0 · Option exercise (M): 96,758 (derivative) @ $0 · +1 more | EDGAR |
| 2022-01-28 | 4 | Adaptive Biotechnologies Corp (ADPT) | Grant/award (A): 6,689 @ $0 · Grant/award (A): 16,722 (derivative) @ $0 | EDGAR |
| 2022-01-19 | 4 | EXACT SCIENCES CORP (EXAS) | Grant/award (A): 6,407 @ $0 | EDGAR |
| 2022-01-04 | 4 | Epizyme, Inc. (EPZM) | Grant/award (A): 6,000 @ $2.50 | EDGAR |
| 2021-11-03 | 4 | EXACT SCIENCES CORP (EXAS) | Sale (S): 16,922 @ $93.88 | EDGAR |
| 2021-10-05 | 4 | EXACT SCIENCES CORP (EXAS) | Sale (S): 17,078 @ $93.64 | EDGAR |
| 2021-10-01 | 4 | Epizyme, Inc. (EPZM) | Grant/award (A): 2,930 @ $5.12 | EDGAR |
| 2021-09-03 | 4 | EXACT SCIENCES CORP (EXAS) | Sale (S): 18,978 @ $104.42 | EDGAR |
| 2021-09-03 | 4 | SomaLogic, Inc. (SLGCW) | Other (J): 25,000 @ $0 · Grant/award (A): 166,666 (derivative) · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2021-08-04 | 4 | EXACT SCIENCES CORP (EXAS) | Sale (S): 19,970 @ $107.50 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-26 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1306119 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs